Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists.
- DOI
- 10.1007/s11095-026-04146-9
- Published
- 2026 Aug
- Container
- Pharmaceutical research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11095-026-04146-9,
title = {Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists.},
author = {Kopp KL and Lamberth K and Schelde O and Øgendahl AK and Wojcieszek M and Mogensen JE and Ramírez-Andersen HS and Schneider CL and Staby A and Hach M},
year = {2026},
journal = {Pharmaceutical research},
doi = {10.1007/s11095-026-04146-9},
url = {https://doi.org/10.1007/s11095-026-04146-9}
}RIS
TY - JOUR TI - Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists. AU - Kopp KL AU - Lamberth K AU - Schelde O AU - Øgendahl AK AU - Wojcieszek M AU - Mogensen JE AU - Ramírez-Andersen HS AU - Schneider CL AU - Staby A AU - Hach M PY - 2026 JO - Pharmaceutical research DO - 10.1007/s11095-026-04146-9 UR - https://doi.org/10.1007/s11095-026-04146-9 ER -
APA
KL, K., K, L., O, S., AK, Ø., M, W., JE, M., HS, R., CL, S., A, S., & M, H. (2026). Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists.. Pharmaceutical research. https://doi.org/10.1007/s11095-026-04146-9
Source records
- pubmed · retrieved 2026-09-25T08:39:12.392Z